COVID-19 in Dental Settings: Novel Risk Assessment Approach †

por Alsaegh, Ali, Belova, Elena, Vasil’ev, Yuriy, Zabroda, Nadezhda, Severova, Lyudmila, Timofeeva, Margarita, Dobrokhotov, Denis, Leonova, Alevtina, Mitrokhin, Oleg
Publicado 2021

Phase 3 Clinical Trial: Perioperative Use of Nonacog Gamma, a Recombinant Factor IX, in Previously Treated Patients With Moderate/Severe Hemophilia B

por Windyga, Jerzy, Timofeeva, Margarita, Stasyshyn, Oleksandra, Mamonov, Vasily, Lamas Castellanos, José Luis, Lissitchkov, Toshko, Chojnowski, Krzysztof, Chapman, Miranda, Pavlova, Borislava G., Tangada, Srilatha
Publicado 2020

SHP656, a polysialylated recombinant factor VIII (PSA‐rFVIII): First‐in‐human study evaluating safety, tolerability and pharmacokinetics in patients with severe haemophilia A

por Tiede, Andreas, Allen, Geoffrey, Bauer, Alexander, Chowdary, Pratima, Collins, Peter, Goldstein, Brahm, Jiang, Hongyu Jeanne, Kӧck, Kathleen, Takács, István, Timofeeva, Margarita, Wolfsegger, Martin, Srivastava, Shouryadeep
Publicado 2019

Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran—Results of the phase 1 inhibitor cohort

por Pasi, K. John, Lissitchkov, Toshko, Mamonov, Vasily, Mant, Tim, Timofeeva, Margarita, Bagot, Catherine, Chowdary, Pratima, Georgiev, Pencho, Gercheva‐Kyuchukova, Liana, Madigan, Kate, Van Nguyen, Huy, Yu, Qifeng, Mei, Baisong, Benson, Craig C., Ragni, Margaret V.
Publicado 2021

Medical Care for Tuberculosis-HIV-Coinfected Patients in Russia with Respect to a Changeable Patients’ Structure

por Frolova, Olga P., Butylchenko, Olga V., Gadzhieva, Patimat G., Timofeeva, Margarita Yu., Basangova, Valeria A., Petrova, Vladislava O., Fadeeva, Inna A., Kashutina, Maria I., Zabroda, Nadezhda N., Basov, Artem A., Belova, Elena V., Zhernov, Yury V., Mitrokhin, Oleg V., Enilenis, Inga I., Severova, Lyudmila P.
Publicado 2022